In 1989, partly as a result of America's participation in the 1972 International Biological Weapons Convention, but also in response to growing concerns about terrorist use of biological weapons, Congress passed the first of a series of bioterrorism acts, this one entitled The Antiterrorism Act of 1989. The next significant piece of legislation to appear had the grim title, The Antiterrorism and Effective Death Penalty Act of 1996. A large-scale, bipartisan effort initiated in 1999 resulted in the Public Health Security and Bioterrorism Preparedness Act of 2002. In March of 2003, a Strategic National Stockpile (SNS)was created to ensure the rapid availability of anti-bioterror medicines and vaccines. Finally, in 2006, Congress produced a National Strategy for Pandemic Influenza. In this chapter, these various plans and strategies are evaluated for their ability to protect America during catastrophic biological emergencies.
Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
If you think you should have access to this title, please contact your librarian.